ANDA 202838, held by Glenmark Pharms Ltd. Desoximetasone.
As of Nov 15, 2026, ANDA 202838 (Desoximetasone), held by Glenmark Pharms Ltd, was first approved by FDA on Sep 20, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 20, 2013 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desoximetasone0.25% ยท ointment;topical | Desoximetasone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
